While other studies have reported Sema3E to have inhibitory effects on melanoma and prostate cancer metastasis [25, 31], they failed to identify and discriminate between the full-length and the cleaved forms of the protein, making it difficult to discern between distinct differences between types of cancer or Sema3E cleavage. This evidence concerns the gene SEMA3E and Familial prostate cancer.